Acquisition of Atrin Pharmaceuticals (Details) $ in Millions		12 Months Ended
	May 16, 2022 USD ($) shares	Dec. 31, 2022 shares
Series A Convertible Preferred Stock
Acquisition of Atrin
Issuance of preferred stock upon acquisition of Atrin (in shares)		2,949,630
Atrin Pharmaceuticals, Inc
Acquisition of Atrin
Cost to acquire Atrin assets | $	$ 76.2
Direct costs of acquisition of Atrin assets | $	$ 3.5
Atrin Pharmaceuticals, Inc | Common Stock
Acquisition of Atrin
Issuance of stock upon acquisition of Atrin (in shares).	55,869
Atrin Pharmaceuticals, Inc | Series A Convertible Preferred Stock
Acquisition of Atrin
Issuance of stock upon acquisition of Atrin (in shares).	2,949,630
Preferred stock conversion ratio	10